Investigation of interindividual factors in nivolumab pharmacokinetics and adverse events in Japanese patients with non-small-cell lung cancer and renal cell cancer
Not Applicable
Recruiting
- Conditions
- on-small-cell lung cancer, renal cell cancer
- Registration Number
- JPRN-UMIN000041082
- Lead Sponsor
- Department of Hospital pharmacy Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are judged by physicians as inappropriate for study enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum nivolumab concentration just before dosing at 7th administration or later
- Secondary Outcome Measures
Name Time Method